Enterome vs N-Zyme Biomedical
Enterome vs N-Zyme Biomedical, compared side by side on 19 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Enterome is on 60/100 and N-Zyme Biomedical on 50/100.
Where each one leads
Enterome
- our overall score: 60/100 against 50/100
- domain rating: 46/100 against 6/100
- headcount: 33 against 5
- funding raised: $124M against $4.6M
- LinkedIn following: 16,846 against 296
N-Zyme Biomedical
- agent readiness: 31/100 against 21/100
At a glance
| Measure | Enterome | N-Zyme Biomedical |
|---|---|---|
| What it is | Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases. | A biotechnology company focused on developing novel enzyme-based therapies for reflux disease. |
| Category | Biotechnology, Drug Discovery, Oncology, Immunotherapy | Biotechnology, Pharmaceuticals, HealthTech, Biotech |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | hardware | services | marketplace | platform | Pharmaceutical |
| Founded | 2012 | 2021 |
| Headquarters | Paris, France | Newark, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Enterome | N-Zyme Biomedical |
|---|---|---|
| Employees | 33 | 5 |
| Total funding | $124M | $4.6M |
| Latest round | Later Stage VC | Series A |
| LinkedIn followers | 16,846 | 296 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Enterome | N-Zyme Biomedical |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 60/100 | 50/100 |
| Traction | 55/100 | 41/100 |
| Team | 70/100 | Not published |
| Search visibility | 34/100 | 32/100 |
| Quality | 68/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (21/100) | F (31/100) |
| Domain ratingLink authority, 0-100 | 46/100 | 6/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Enterome | N-Zyme Biomedical |
|---|---|---|
| Hosting | Self Managed | Not detected |
| CDN | Not detected | Cloudflare |
| CMS | WordPress | Webflow |
| Frameworks | Bootstrap | Not detected |
| Analytics | Google Analytics 4, Segment | Hotjar |
What users say
| Measure | Enterome | N-Zyme Biomedical |
|---|---|---|
| Reddit sentimentThreads we track | Not published | 0 positive, 0 negative across 1 thread |
“N-Zyme Biomedical Begins Phase 2 Trial of First Pepsin Inhibitor for Reflux Disease. What does this mean? Are they closer to the drug?”r/LPR
Enterome vs N-Zyme Biomedical: common questions
Which is better, Enterome or N-Zyme Biomedical?
On our 0-100 score Enterome rates higher (60/100 against 50/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 19 data points above: read the rows that match what you are buying for.
How do Enterome and N-Zyme Biomedical compare on the numbers?
Enterome leads on our overall score (60/100 against 50/100), domain rating (46/100 against 6/100), headcount (33 against 5), funding raised ($124M against $4.6M), LinkedIn following (16,846 against 296). N-Zyme Biomedical leads on agent readiness (31/100 against 21/100).
What do real users say about Enterome and N-Zyme Biomedical?
N-Zyme Biomedical: 0 positive and 0 negative mentions across 1 Reddit threads we track, mostly in r/LPR.
Read the full Enterome review and pricing or the N-Zyme Biomedical review and pricing. You can also browse other Enterome alternatives we track.